BloodSmart

The BloodSmart® Transfusion Guidelines App. is a clinical reference tool developed to support physicians, healthcare professionals and medical students practicing in any department involved in the treatment of adult patients with possible transfusion needs. This practical and dynamic app. combines essential clinical detail to assist in managing patient needs before, during and after a transfusion. The tool includes:

--Transfusion Guidelines: These guidelines are meant to serve as a foundational basis for determining whether or not to transfuse a patient. Guidelines for transfusion are provided for Red Blood Cells (RBC), Apheresis Platelets, Plasma, Cryoprecipitate and specialty products including washed RBCs and Albumin-Resuspended Platelets.

--Transfusion Reactions: This material provides guidance on the recognition, investigation and management of acute adverse reactions to blood components.

--Informed Consent and Patient Education: This material addresses the process of informed consent and patient education required prior to the administration of blood products in non-emergent settings.

The app. is designed to be a concise reference tool with easy to use tabs and multifunctional pages for a clear and responsive result to your search. BloodSmart has designed this app to be a guidance to provide a safer and more effective transfusion.

BloodSmart® is a comprehensive patient blood management program offered through personal consultation and web-based tools. Developed by California-based BloodSource, a leading not-for-profit blood center, BloodSmart® offers hospitals a tailored, hands-on program created and provided by an internationally recognized medical team with decades of transfusion management experience.

BloodSmart® improves patient safety and outcomes by providing consultation regarding the type, mix and amount of blood products related to patient need. The expertise of the BloodSmart® team can lead to faster recovery times and shortened hospital stays. These results are better for patients and help decrease overall costs related to transfusion medicine.